<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27578313</article-id><article-id pub-id-type="pmc">5005994</article-id><article-id pub-id-type="pii">srep30354</article-id><article-id pub-id-type="doi">10.1038/srep30354</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Impact of Preemptive Analgesia on inflammatory responses and Rehabilitation after Primary Total Knee Arthroplasty: A Controlled Clinical Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jianda</surname><given-names>Xu</given-names></name><xref ref-type="aff" rid="a1">1</xref></contrib><contrib contrib-type="author"><name><surname>Yuxing</surname><given-names>Qu</given-names></name><xref ref-type="aff" rid="a2">2</xref></contrib><contrib contrib-type="author"><name><surname>Yi</surname><given-names>Gao</given-names></name><xref ref-type="aff" rid="a3">3</xref></contrib><contrib contrib-type="author"><name><surname>Hong</surname><given-names>Zhao</given-names></name><xref ref-type="aff" rid="a3">3</xref></contrib><contrib contrib-type="author"><name><surname>Libo</surname><given-names>Peng</given-names></name><xref ref-type="aff" rid="a3">3</xref></contrib><contrib contrib-type="author"><name><surname>Jianning</surname><given-names>Zhao</given-names></name><xref ref-type="corresp" rid="c1">a</xref><xref ref-type="aff" rid="a4">4</xref></contrib><aff id="a1"><label>1</label><institution>Department of Orthopaedics, School of Medicine, Southern Medical University (Guangzhou), Jinling Hospital</institution>, 305 East Zhongshan Road, Nanjing, 210002, Jiangsu Province, <country>China</country></aff><aff id="a2"><label>2</label><institution>Department of Orthopaedics, Changzhou Traditional Chinese medical hospital</institution>, changzhou, 213003, <country>China</country></aff><aff id="a3"><label>3</label><institution>Department of Orthopaedics, Changzhou Traditional Chinese medical hospital</institution>, changzhou, 213003, <country>China</country></aff><aff id="a4"><label>4</label><institution>Department of Orthopaedics, School of Medicine, Southern Medical University (Guangzhou), Jinling Hospital</institution>, 305 East Zhongshan Road, Nanjing, 210002, Jiangsu Province, <country>China</country>.</aff></contrib-group><author-notes><corresp id="c1"><label>a</label><email>zhaojianningnj@sina.com</email></corresp></author-notes><pub-date pub-type="epub"><day>31</day><month>08</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>6</volume><elocation-id>30354</elocation-id><history><date date-type="received"><day>04</day><month>03</month><year>2016</year></date><date date-type="accepted"><day>20</day><month>06</month><year>2016</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2016, The Author(s)</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>The Author(s)</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><!--author-paid--><license-p>This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license></permissions><abstract><p>The aim of this study was to investigate the effects of preemptive analgesia on the inflammatory response and rehabilitation in TKA. 75 patients with unilateral primary knee osteoarthritis were conducted in this prospective study. All patients were randomly divided into two groups (MMA with/without preemptive analgesia group). The following parameters were used to evaluate analgesic efficacy: knee flexion, pain at rest and walking, functional walking capacity (2&#x02009;MWT and 6&#x02009;MWT), WOMAC score, and hs-CRP level. Patients in MMA with preemptive analgesia group had lower hs-CRP level and less pain at rest and walking during the first week postoperatively (P&#x02009;&#x0003c;&#x02009;0.05). The 2&#x02009;MWT was significantly better in MMA with preemptive analgesia group (17.13&#x02009;&#x000b1;&#x02009;3.82 VS 14.19&#x02009;&#x000b1;&#x02009;3.56, P&#x02009;=&#x02009;0.001). The 6&#x02009;MWT scores and WOMAC scores increased significantly within Groups (P&#x02009;=&#x02009;0.020, 0.000), but no difference between groups postoperatively (P&#x02009;&#x0003e;&#x02009;0.05). Less cumulative consumption of morphine was found in MMA with preemptive analgesia group at 48&#x02009;h (P&#x02009;=&#x02009;0.017, 0.023), but no difference at total requirement (P&#x02009;=&#x02009;0.113). Preemptive analgesia added to a multimodal analgesic regime improved analgesia, reduced inflammatory reaction and accelerated functional recovery at the first week postoperatively, but not improved long-term function.</p></abstract></article-meta></front><body><p>The total knee arthroplasty (TKA) has been considered as a leading surgical treatment for advanced arthritis, but severe postoperative pain is still a major complaint of patients<xref ref-type="bibr" rid="b1">1</xref>. The postoperative pain directly results in a prolonged rehabilitation process and worse clinical outcome<xref ref-type="bibr" rid="b2">2</xref><xref ref-type="bibr" rid="b3">3</xref>. Ranawat <italic>et al</italic>. found that postoperative pain was related with arthrofibrosis which diminished range of motion<xref ref-type="bibr" rid="b4">4</xref>.</p><p>In latest decades, many substantial innovations improve perioperative analgesia, including continuous epidural analgesic technique, intravenous patient-controlled analgesia and peripheral nerve blockade. Although each method has been considered effectively in relieving postoperative pain, side effects can hardly be avoided. Multimodal approaches (MMA) provides a better choice with minimizing side effects<xref ref-type="bibr" rid="b5">5</xref>. Despite an extensive, multimodal analgesic approach, considerable acute pain is still appearance after TKA<xref ref-type="bibr" rid="b6">6</xref>. It&#x02019;s believed that preemptive treatment can reduce the consumption of other analgesics, improve analgesic efficacy, and ameliorate immune function. As a selective cyclooxygenase (COX)-2 inhibitor, Celecoxib decreases the post-operative hyperalgesic state by inhibiting prostaglandin synthesis in the periphery and the spinal cord<xref ref-type="bibr" rid="b7">7</xref>. To achieve better postoperative analgesia for faster rehabilitation postoperatively, oral celecoxib preemptively was used.</p><p>Inflammatory reaction is a major component of surgical stress response<xref ref-type="bibr" rid="b8">8</xref>. Shen <italic>et al</italic>. found that C-reactive protein considerablly increased in patients with total knee arthroplasty<xref ref-type="bibr" rid="b9">9</xref>. C-reactive protein (CRP) is produced rapidly in response to inflammation, infection, tissue damage, and malignancy<xref ref-type="bibr" rid="b10">10</xref>. Sturmer <italic>et al</italic>. found that elevated levels of CRP was correlated with symptoms of pain, stiffness, and radiographic grading in OA<xref ref-type="bibr" rid="b11">11</xref>. To our knowledge, the effect of preemptive analgesia on the inflammatory response in TKA has not been studied.</p><p>The aim of this study was to investigate the effects of preemptive analgesia on the inflammatory response in patients with or without preemptive analgesia. In addition, we investigated whether preemptive analgesia leaded to low postoperative pain and better rehabilitation.</p><sec disp-level="1"><title>Patients and Methods</title><p>The study protocol was approved by the Ethics Review Committee of Changzhou Traditional Chinese Medical Hospital, affiliated to Nanjing University of Traditional Chinese Medicine. Verbal and written informed consents were obtained before all study. The study was carried out in accordance with the approved guidelines.</p><p>From February 2013 to February 2014, seventy-five patients, ASA I&#x02013;III, aged 54&#x02013;76 (average, 68.3&#x02009;&#x000b1;&#x02009;6.5) years, diagnosed with unilateral primary knee osteoarthritis(50 females and 25 males) were conducted in this prospective study. All enrolled patients were randomly allocated using a random-number table to receive MMA with/without preemptive analgesia. Exclusion criteria included inflammatory arthritis, alcohol or medical abuses, autoimmune disorder used steroid medication, and neurologic or psychiatric diseases potentially influencing pain perception.</p><p>All surgeries were done by one experienced orthopaedic surgeon with a specialist interest in arthroplasty. Prostheses were rotating platform for artificial knee joint (GEMINI MKII, Link Inc., Germany). The routine anaesthesia method were lumbar spinal anaesthesia (34 patients, 45.3%) or general Anaesthesia (41 patients, 54.7%). The tourniquet and wound drain were used in each case, and the drain was removed after 48&#x02009;h postoperatively. Low Molecular Weight Heparin Sodium (Sanofi Winthrop Industrie, France, 0.6&#x02009;ml:6000AxaIU) was used for thromboprophylaxis once daily post- operatively until discharge. The hospital stay was 14 days postoperatively. Mobilization started from the day of surgery with the same rehabilitation scheme by one physiotherapist. After satisfactory radiograph, patients would leave the bed ambulating with walking aids. While on the bed, they would sit on the edge of the bed dependent on their tolerance. On the following days, patients attended rehabilitation twice a day to perform exercises. According to the patient&#x02019;s tolerance, the distance increased gradually.</p><p>Follow-up duration was defined as the date of operation to the date of last visit. Range of motion (ROM), pain at rest, pain at walking were measured at 8:30&#x02009;a.m. during hospitalization. Hospital narcotic analgesic use, side-effects and complications were also recorded during hospitalization. After discharge, pain, ROM and functional results were evaluated at each follow-up. All parameters were measured before operation.</p><sec disp-level="2"><title>Preemptive Analgesia and MMA</title><p>A preemptive oral analgesic regimen of celecoxib (200&#x02009;mg, Pfizer, America; 400&#x02009;mg, PO) was administered to each patient within 1&#x02009;hour before operation without any other premedication<xref ref-type="bibr" rid="b12">12</xref><xref ref-type="bibr" rid="b13">13</xref><xref ref-type="bibr" rid="b14">14</xref><xref ref-type="bibr" rid="b15">15</xref>.</p><p>A standardized, multimodal analgesic regime with cocktail injection was administrated. The cocktail (combination of Ropivacaine 357.6&#x02009;mg, morphine 5&#x02009;mg, adrenaline 0.3&#x02009;mg, ketorolac 30&#x02009;mg) was administered pre- and post-cementation. The first injection was administered to posterior capsule, posteromedial structures and periarticular synovium. The second injection was administered to extensor mechanism, pes anserinus, anteromedial capsule, periosteum, iliotibial band and subcutaneous plane<xref ref-type="bibr" rid="b16">16</xref>.</p><p>As a primary analgesic, celecoxib (200&#x02009;mg PO) was administered twice daily starting 12&#x02009;hours postoperatively and continued throughout their hospital stay<xref ref-type="bibr" rid="b17">17</xref>. Subcutaneous morphine was used when the oral analgesics was not effective. All narcotic use was recorded. Post-operative nausea and vomiting (PONV) was treated with ondansetron.</p></sec><sec disp-level="2"><title>Analysis of blood samples</title><p>Systemic inflammation was measured by high-sensitivity C-reactive protein (hs-CRP) in venous blood before operation, daily at the first week, 2 weeks, 1, 3, 6 months after surgery. Venous blood sample was taken from each patient at 7&#x02009;a.m.</p><p>Hs-CRP was tested by Simens BN II analyser (Simens Healthcare Diagnostics Products GmbH, Marburg, Germany) according to the manufacturer&#x02019;s instructions. The normal range for Hs-CRP values: Low risk &#x02264;1&#x02009;mg/L. Normal&#x02009;=&#x02009;1&#x02013;3&#x02009;mg/L. High risk &#x02265;3&#x02009;mg/L.</p></sec><sec disp-level="2"><title>Study clinical parameters</title><sec disp-level="3"><title>Knee Flexion</title><p>Knee flexion was measured in supine lying using a goniometer<xref ref-type="bibr" rid="b18">18</xref>.</p></sec><sec disp-level="3"><title>Pain</title><p>The quality of postoperative pain relief was measured by morphine consumption and the visual analogue scale. Patients were asked to mark their level of pain on a 10&#x02009;cm visual analogue scale<xref ref-type="bibr" rid="b19">19</xref>. Pain at rest was evaluated after 30&#x02009;min rest. Pain on walking or knee maximal flexion was also recorded.</p></sec></sec><sec disp-level="2"><title>Functional walking capacity</title><p>The 2&#x02009;min walk test (2&#x02009;MWT) and 6&#x02009;min walk test (6&#x02009;MWT) were used to evaluate functional walking capacity<xref ref-type="bibr" rid="b20">20</xref>. The distance covered was recorded in metres. Baseline-predicted 2&#x02009;MWT and 6&#x02009;MWT distance was calculated using gender-specific reference equations for the 6&#x02009;MWT<xref ref-type="bibr" rid="b21">21</xref>.</p></sec><sec disp-level="2"><title>Assessment of knee function</title><p>The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) was administered to assess the knee function<xref ref-type="bibr" rid="b22">22</xref>.</p></sec><sec disp-level="2"><title>Statistical analysis</title><p>The normality of distribution for continuous numeric variables was assessed by Kolmogorov&#x02013;Smirnov test. According to normally distributed or not, the variables are presented as means with SD, and otherwise as medians with inter-quartile ranges (95% confidence intervals, 95% CI). Student&#x02019;s t-test for normally distributed continuous variables, while others using Pearson&#x02019;s &#x003c7;<sup>2</sup> test or Wilcoxon&#x02019;s rank sum test.</p><p>Continuous data with repeated measures were analysed using repeated-measures regressions for general linear models. Bivariate analysis was used to analysis the relation of different studied variables.</p><p>The SPSS statistical package (Version 17.0, SPSS Inc., Chicago, IL, USA) was used for statistical analyses. P&#x02009;&#x0003c;&#x02009;0.05 was considered as a positive significance.</p></sec></sec><sec disp-level="1"><title>Results</title><p>Seventy-five patients were assessed for eligibility in this study and randomly divided into two groups (MMA with/without preemptive analgesia group). Baseline pre- and perioperative was similar in both groups (<xref ref-type="table" rid="t1">Table 1</xref>).</p><sec disp-level="2"><title>hs-CRP and Pain</title><p>Patients in MMA with preemptive analgesia group had lower hs-CRP level during the first week postoperatively (P&#x02009;&#x0003c;&#x02009;0.05, <xref ref-type="fig" rid="f1">Fig. 1A</xref>). The CRP levels in both groups increased rapidly and peaked 3 days postoperatively at maximum levels(104.46&#x02009;&#x000b1;&#x02009;10.67 Vs 153.63&#x02009;&#x000b1;&#x02009;11.11).</p><p>No difference was found after 7 days postoperatively. The CRP then fell to preoperative values gradually and eventually returned to normal by 2 weeks postoperatively.</p><p>The hs-CRP level was positively correlated with pain at rest and walking (correlation coefficient 0.398/0.377, P&#x02009;=&#x02009;0.000, 0.000), but negatively correlated with ROM (correlation coefficient &#x02212;0.741, P&#x02009;=&#x02009;0.000).</p></sec><sec disp-level="2"><title>Pain and rescue analgesic requirement</title><p>Less pain at rest and walking were found in MMA with preemptive analgesia group (P&#x02009;&#x0003c;&#x02009;0.05), but no difference after the first week. No significance was found about severe pain at rest or during walking on the further follow-up (<xref ref-type="fig" rid="f1">Fig. 1B,C</xref>).</p><p>On the follow-up of three months, one patient in MMA with preemptive analgesia group and two patients in MMA without preemptive analgesia group reported moderate pain during walking and recovered by celecoxib.</p><p>Less cumulative consumption of morphine was found in the MMA with preemptive analgesia group from 0 to 48&#x02009;h (P&#x02009;=&#x02009;0.017, 0.023, <xref ref-type="table" rid="t2">Table 2</xref>), but no total morphine requirement difference during the remaining study period (P&#x02009;=&#x02009;0.113, <xref ref-type="table" rid="t3">Table 3</xref>).</p></sec><sec disp-level="2"><title>Functional results</title><sec disp-level="3"><title>Early postoperative functional outcome measures</title><p>All patients leaved the bed ambulating with weight-bearing with walking aids on days 2 or 3.</p><p>The 2&#x02009;MWT was significantly better in MMA with preemptive analgesia group (17.13&#x02009;&#x000b1;&#x02009;3.82 VS 14.19&#x02009;&#x000b1;&#x02009;3.56, P&#x02009;=&#x02009;0.001), but no differences on day 7 and week 2 (P&#x02009;=&#x02009;0.148, 0.108, <xref ref-type="table" rid="t4">Table 4</xref>). ROM) after arthroplasty has the same results (<xref ref-type="fig" rid="f1">Fig. 1D</xref>).</p></sec><sec disp-level="3"><title>Late postoperative functional outcome</title><p>The preoperative 6&#x02009;MWT was similar in both groups (P&#x02009;=&#x02009;0.392). When repeated 1, 3, 6 months postoperatively, the 6&#x02009;MWT scores increased significantly within groups (P&#x02009;=&#x02009;0.020), but no difference was found in both groups (P&#x02009;=&#x02009;0.153, 0.735, 0.973 ).</p><p>Similarly, the changes in WOMAC scores were statistically significant (P&#x02009;=&#x02009;0.000), with no difference between groups (P&#x02009;=&#x02009;0.914, 0.111, 0.992, <xref ref-type="table" rid="t3">Table 3</xref>).</p></sec><sec disp-level="3"><title>Postoperative Complications</title><p>There was no obvious side-effects or complications related to drug during hospitalization or on further follow-up. In present study, no superficial or deep infections occurred (<xref ref-type="table" rid="t4">Table 4</xref>). None bleeding complication was found in this current study.</p><p>The incidence of PONV and No. of patients requiring ondansetron were overall low. Compared with MMA without preemptive analgesia group, no significant difference was found about the number of patients with nausea, vomiting and requiring ondansetron (P&#x02009;&#x0003e;&#x02009;0.05, <xref ref-type="table" rid="t4">Table 4</xref>).</p></sec></sec></sec><sec disp-level="1"><title>Discussion</title><p>Surgical trauma usually induces an inflammatory state with the release of pro- and anti-inflammatory proteins. Surgeons recognized that suppression of the inflammatory response could decrease the complications, due to less inflammatory mediators in nociceptive processing<xref ref-type="bibr" rid="b23">23</xref><xref ref-type="bibr" rid="b24">24</xref>. Preemptive analgesia is initiated to prevent the peripheral and central nociception before the noxious stimulus arises. To overcome inflammatory responses, different drugs are being tried by the technique. These trials cover NSAIDs, opioids, NMDA receptor antagonists and systemic antiepileptics<xref ref-type="bibr" rid="b25">25</xref><xref ref-type="bibr" rid="b26">26</xref><xref ref-type="bibr" rid="b27">27</xref><xref ref-type="bibr" rid="b28">28</xref>. Stephens <italic>et al</italic>. had found that NSAIDs was important in extending the analgesia of multimodal analgesia, and improved clinical outcomes after surgery<xref ref-type="bibr" rid="b29">29</xref>. Considering the aim of attenuating the peripheral and central nociception and side effects, we preferred dedicated COX-2 inhibitor celecoxib as preemptive analgesia oral analgesic regimen. Digestive complications, homeostasis, and negative effects on bone repairing will be improved by taking selective inhibitors of Cox-2 in comparison to ordinary NSAID<xref ref-type="bibr" rid="b30">30</xref>. Preemptive analgesia oral analgesic regimen of celecoxib could effectively attenuate the establishment of hyperalgesia by suppressing afferent and efferent fibers by attenuating inflammatory response.</p><p>In present study, we did see a slash reduction in hs-CRP level and pain score in the MMA with preemptive analgesia group. The level of hs-CRP increased in both groups, with a peak at the third day post-operatively and gradually normalized. In both groups, hs-CRP level rised faster compared with latter degression.</p><p>The pain was significantly reduced in the first week postoperatively in MMA with preemptive analgesia group. No difference was found after 1week postoperatively. Despite we prolonged the assessment of pain upon rest and walking, no prolonged analgesic effect was observed. Lunn TH, <italic>et al</italic>. have demonstrated that a single preoperative high dose of MP (125&#x02009;mg i.v.) could reduce the overall pain for the first 48&#x02009;h after TKA, and improve analgesia and immediate recovery postoperatively<xref ref-type="bibr" rid="b31">31</xref>. De Oliveira GS <italic>et al</italic>. concluded that a certain amount of glucocorticoid was necessary for reducing opioid consumption and postoperative pain<xref ref-type="bibr" rid="b32">32</xref>. Hall GM <italic>et al</italic>. studied the relationship between inflammatory responses and functional recovery in hip arthroplasty, and concluded that the inflammatory response was related with immediate functional recovery. And attenuation of the inflammatory meant less pain and better functional recovery<xref ref-type="bibr" rid="b33">33</xref>.</p><p>Celecoxib could effectively attenuate the hyperalgesia of afferent and efferent fibers by attenuating inflammatory response. Previous study had concluded that local anesthetics could modulate the inflammatory response in mice systemically or locally<xref ref-type="bibr" rid="b34">34</xref>. Sinclair <italic>et al</italic>. found that amide local anesthetics could suppress markedly the metabolic activation and secretory function of leukocytes in a dose-dependent manner<xref ref-type="bibr" rid="b35">35</xref>. This may explain the difference of hs-CRP levels in MMA with/without preemptive analgesia group was mediated by preemptive analgesia oral analgesic regime.</p><p>The nerve fibers around surgical area of the knee covers: the femoral nerve (anterior), the obturator nerve (medial), the lateral femoral cutaneous nerve (lateral) and the sciatic nerve (posterior). Periarticular infiltration of local anaesthetics may provide good analgesia locally and improve walking capacity<xref ref-type="bibr" rid="b36">36</xref>. Therefore, we administered local injection to all areas of the knee. And the pain intensity in the present study showed adequately nerve blocked.</p><p>Because of less use of opioids in both groups, PONV was not a serious clinical problem<xref ref-type="bibr" rid="b37">37</xref>, and no significant difference was found.</p><p>Our study did not supply a more detailed explanation for the preemptive analgesic benefit. However, suppressing the system inflammatory response (hs-CRP) means less inflammatory mediators in nociceptive processing<xref ref-type="bibr" rid="b23">23</xref>.</p><p>Our study had several strengths: this was a prospective controlled study. All patients were screened and followed at one single centre and received standardized pre-, peri-, and postoperative regime. The detailed assessment of outcomes was collected by one single data collector, resulting in few missing data.</p><p>However, there were also limitations to our study, including a relatively small sample size. Nevertheless the small number of patients illustrated the importance of preemptive analgesia on inflammatory response and postoperative functional outcome.</p><p>In conclusion, preemptive analgesia oral analgesic regimen added to a multimodal analgesic regime improved analgesia, reduced inflammatory reaction and accelerated functional recovery atthe first postoperative week, but not improved long-term function. Therefore, these outcomes are important to determine optimal pain management after TKA.</p></sec><sec disp-level="1"><title>Additional Information</title><p><bold>How to cite this article</bold>: Jianda, X. <italic>et al</italic>. Impact of Preemptive Analgesia on inflammatory responses and Rehabilitation after Primary Total Knee Arthroplasty: A Controlled Clinical Study. <italic>Sci. Rep.</italic>
<bold>6</bold>, 30354; doi: 10.1038/srep30354 (2016).</p></sec></body><back><ref-list><ref id="b1"><mixed-citation publication-type="journal"><name><surname>Rodriguez</surname><given-names>J. A.</given-names></name>, <name><surname>Bhende</surname><given-names>H.</given-names></name> &#x00026; <name><surname>Ranawat</surname><given-names>C. S.</given-names></name>
<article-title>Total condylar knee replacement:a 20-year followup study</article-title>. <source>Clin Orthop Relat Res.</source>
<volume>388</volume>, <fpage>10</fpage>&#x02013;<lpage>17</lpage> (<year>2001</year>).<pub-id pub-id-type="pmid">11451106</pub-id></mixed-citation></ref><ref id="b2"><mixed-citation publication-type="journal"><name><surname>Ilfeld</surname><given-names>B. M.</given-names></name>
<etal/>. <article-title>Ambulatory continuous femoral nerve blocks decrease time to discharge readiness after tricompartment total knee arthroplasty: a randomized, triple-masked, placebo-controlled study</article-title>. <source>Anesthesiology.</source>
<volume>108</volume>(4), <fpage>703</fpage>&#x02013;<lpage>713</lpage> (<year>2008</year>).<pub-id pub-id-type="pmid">18362603</pub-id></mixed-citation></ref><ref id="b3"><mixed-citation publication-type="journal"><name><surname>Capdevila</surname><given-names>X.</given-names></name>
<etal/>. <article-title>Effects of perioperative analgesic technique on the surgical outcome and duration of rehabilitation after major knee surgery</article-title>. <source>Anesthesiology.</source>
<volume>91</volume>(1), <fpage>8</fpage>&#x02013;<lpage>15</lpage> (<year>1999</year>).<pub-id pub-id-type="pmid">10422923</pub-id></mixed-citation></ref><ref id="b4"><mixed-citation publication-type="journal"><name><surname>Ranawat</surname><given-names>C. S.</given-names></name>, <name><surname>Ranawat</surname><given-names>A. S.</given-names></name> &#x00026; <name><surname>Mehta</surname><given-names>A.</given-names></name>
<article-title>Total knee arthroplasty rehabilitation protocol: what makes the difference?</article-title>
<source>J Arthroplasty.</source>
<volume>18</volume>(1)(Suppl 1), <fpage>27</fpage>&#x02013;<lpage>30</lpage> (<year>2003</year>).<pub-id pub-id-type="pmid">12730924</pub-id></mixed-citation></ref><ref id="b5"><mixed-citation publication-type="journal"><name><surname>Maheshwari</surname><given-names>A. V.</given-names></name>, <name><surname>Blum</surname><given-names>Y. C.</given-names></name> &#x00026; <name><surname>Shekhar</surname><given-names>L.</given-names></name>
<article-title>Multimodal Pain Management after Total Hip and Knee Arthroplasty at the Ranawat Orthopaedic Center</article-title>. <source>Clin Orthop Relat Res.</source>
<volume>467</volume>, <fpage>1418</fpage>&#x02013;<lpage>1423</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19214642</pub-id></mixed-citation></ref><ref id="b6"><mixed-citation publication-type="journal"><name><surname>Andersen</surname><given-names>L. O.</given-names></name>
<etal/>. <article-title>Subacute pain and function after fast-track hip and knee arthroplasty</article-title>. <source>Anaesthesia.</source>
<volume>64</volume>, <fpage>508</fpage>&#x02013;<lpage>513</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19413820</pub-id></mixed-citation></ref><ref id="b7"><mixed-citation publication-type="journal"><name><surname>McCormack</surname><given-names>K.</given-names></name>
<article-title>Non-steroidal anti-inflammatory drugs and spinal nociceptive processing</article-title>. <source>Pain.</source>
<volume>59</volume>(1), <fpage>9</fpage>&#x02013;<lpage>43</lpage> (<year>1994</year>).<pub-id pub-id-type="pmid">7854808</pub-id></mixed-citation></ref><ref id="b8"><mixed-citation publication-type="journal"><name><surname>Giannoudis</surname><given-names>P. V.</given-names></name>, <name><surname>Dinopoulos</surname><given-names>H.</given-names></name>, <name><surname>Chalidis</surname><given-names>B.</given-names></name> &#x00026; <name><surname>Hall</surname><given-names>G. M.</given-names></name>
<article-title>Surgical stress response</article-title>. <source>Injury</source>
<volume>37</volume> (Suppl 5), <fpage>S3</fpage>&#x02013;<lpage>S9</lpage> (<year>2006</year>).<pub-id pub-id-type="pmid">17338909</pub-id></mixed-citation></ref><ref id="b9"><mixed-citation publication-type="journal"><name><surname>Shen</surname><given-names>H.</given-names></name>, <name><surname>Zhang</surname><given-names>N.</given-names></name>, <name><surname>Zhang</surname><given-names>X.</given-names></name> &#x00026; <name><surname>Ji</surname><given-names>W.</given-names></name>
<article-title>C-reactive protein levels after 4 types of arthroplasty</article-title>. <source>Acta Orthop.</source>
<volume>80</volume>, <fpage>330</fpage>&#x02013;<lpage>333</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19593724</pub-id></mixed-citation></ref><ref id="b10"><mixed-citation publication-type="journal"><name><surname>Kushner</surname><given-names>I.</given-names></name>, <name><surname>Gewurz</surname><given-names>H.</given-names></name> &#x00026; <name><surname>Benson</surname><given-names>M. D.</given-names></name>
<article-title>C-reactive protein and the acute phase response</article-title>. <source>J Lab Clin Med.</source>
<volume>97</volume>, <fpage>739</fpage>&#x02013;<lpage>749</lpage> (<year>1981</year>).<pub-id pub-id-type="pmid">7229508</pub-id></mixed-citation></ref><ref id="b11"><mixed-citation publication-type="journal"><name><surname>Sturmer</surname><given-names>T.</given-names></name>, <name><surname>Brenner</surname><given-names>H.</given-names></name>, <name><surname>Koenig</surname><given-names>W.</given-names></name> &#x00026; <name><surname>Gunther</surname><given-names>K.</given-names></name>
<article-title>Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein</article-title>. <source>Ann Rheum Dis.</source>
<volume>6</volume>, <fpage>200</fpage>&#x02013;<lpage>205</lpage> (<year>2004</year>).<pub-id pub-id-type="pmid">14722211</pub-id></mixed-citation></ref><ref id="b12"><mixed-citation publication-type="journal"><name><surname>Mardani-Kivi</surname><given-names>M.</given-names></name>
<etal/>. <article-title>Celecoxib as a pre-emptive analgesia after arthroscopic knee surgery: a triple-blinded randomized controlled trial</article-title>. <source>Arch Orthop Trauma Surg.</source>
<volume>133</volume>(11), <fpage>1561</fpage>&#x02013;<lpage>1566</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">24043481</pub-id></mixed-citation></ref><ref id="b13"><mixed-citation publication-type="journal"><name><surname>Al-Sukhun</surname><given-names>J.</given-names></name>, <name><surname>Al-Sukhun</surname><given-names>S.</given-names></name>, <name><surname>Penttil&#x000e4;</surname><given-names>H.</given-names></name> &#x00026; <name><surname>Ashammakhi</surname><given-names>N.</given-names></name>
<article-title>Preemptive analgesic effect of low doses of celecoxib is superior to low doses of traditional nonsteroidal anti-inflammatory drugs</article-title>. <source>J Craniofac Surg.</source>
<volume>23</volume>(2), <fpage>526</fpage>&#x02013;<lpage>529</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22421863</pub-id></mixed-citation></ref><ref id="b14"><mixed-citation publication-type="journal"><name><surname>Scott</surname><given-names>S.</given-names></name>, Reuben, <name><surname>Evan</surname><given-names>F.</given-names></name> &#x00026; <name><surname>Ekman</surname><given-names>Derek Charron</given-names></name>
<article-title>Evaluating the Analgesic Efficacy of Administering Celecoxib as a Component of Multimodal Analgesia for Outpatient Anterior Cruciate Ligament Reconstruction Surgery</article-title>. <source>Anesthesia &#x00026; Amalgesia.</source>
<volume>105</volume>(1), <fpage>222</fpage>&#x02013;<lpage>227</lpage> (<year>2007</year>).</mixed-citation></ref><ref id="b15"><mixed-citation publication-type="journal"><name><surname>Straube</surname><given-names>S.</given-names></name>, <name><surname>Derry</surname><given-names>S.</given-names></name>, <name><surname>McQuay</surname><given-names>H. J.</given-names></name> &#x00026; <name><surname>Moore</surname><given-names>R. A.</given-names></name>
<article-title>Effect of preoperative Cox-II-selective NSAIDs (coxibs) on postoperative outcomes: a systematic review of randomized studies</article-title>. <source>Acta anaesthesiologica Scandinavica.</source>
<volume>49</volume>(5), <fpage>601</fpage>&#x02013;<lpage>613</lpage> (<year>2005</year>).<pub-id pub-id-type="pmid">15836672</pub-id></mixed-citation></ref><ref id="b16"><mixed-citation publication-type="journal"><name><surname>Meftah</surname><given-names>M.</given-names></name>
<etal/>. <article-title>Pain Management After Total Knee Arthroplasty Using a Multimodal Approach</article-title>. <source>Orhopaedics.</source>
<fpage>e660</fpage>&#x02013;<lpage>e664</lpage> (<year>2012</year>).</mixed-citation></ref><ref id="b17"><mixed-citation publication-type="journal"><name><surname>Lauren</surname><given-names>A.</given-names></name>
<name><surname>Beaupre</surname><given-names>D.</given-names></name> &#x00026; <name><surname>Bill</surname><given-names>C.</given-names></name>
<article-title>Johnston, Sherry Dieleman, Ban Tsui. Impact of a preemptive multimodal analgesia plus femoral nerve blockade protocol on rehabilitation, hospital length of stay, and postoperative analgesia after primary total knee arthroplasty: A controlled clinical pilot study</article-title>. <source>The Scientific World Journal.</source>
<volume>5</volume>, <fpage>1</fpage>&#x02013;<lpage>6</lpage> (<year>2012</year>).</mixed-citation></ref><ref id="b18"><mixed-citation publication-type="journal"><name><surname>Gogia</surname><given-names>P. P.</given-names></name>, <name><surname>Braatz</surname><given-names>J. H.</given-names></name>, <name><surname>Rose</surname><given-names>S. J.</given-names></name> &#x00026; <name><surname>Norton</surname><given-names>B. J.</given-names></name>
<article-title>Reliability and validity of goniometric measurements at the knee</article-title>. <source>Physical Therapy.</source>
<volume>67</volume>(2), <fpage>192</fpage>&#x02013;<lpage>195</lpage> (<year>1987</year>).<pub-id pub-id-type="pmid">3809242</pub-id></mixed-citation></ref><ref id="b19"><mixed-citation publication-type="journal"><name><surname>Stubbs</surname><given-names>D. F.</given-names></name>
<article-title>Visual analogue scale</article-title>. <source>Br J Clin Pharmacol.</source>
<volume>7</volume>, <fpage>124</fpage> (<year>1979</year>).<pub-id pub-id-type="pmid">760737</pub-id></mixed-citation></ref><ref id="b20"><mixed-citation publication-type="journal"><name><surname>Butland</surname><given-names>R. J.</given-names></name>, <name><surname>Pang</surname><given-names>J.</given-names></name>, <name><surname>Gross</surname><given-names>E. R.</given-names></name>, <name><surname>Woodcock</surname><given-names>A. A.</given-names></name> &#x00026; <name><surname>Geddes</surname><given-names>D. M.</given-names></name>
<article-title>Two-, six-, and 12-minute walking tests in respiratory disease</article-title>. <source>Br Med J (Clin Res Ed).</source>
<volume>284</volume>, <fpage>1607</fpage>&#x02013;<lpage>1608</lpage> (<year>1982</year>).</mixed-citation></ref><ref id="b21"><mixed-citation publication-type="journal"><name><surname>Gibbons</surname><given-names>W. J.</given-names></name>, <name><surname>Fruchter</surname><given-names>N.</given-names></name>, <name><surname>Sloan</surname><given-names>S.</given-names></name> &#x00026; <name><surname>Levy</surname><given-names>R. D.</given-names></name>
<article-title>Reference values for a multiple repetition 6-minute walk test in healthy adults older than 20 years</article-title>. <source>J Cardiopulm Rehabil.</source>
<volume>21</volume>, <fpage>87</fpage>&#x02013;<lpage>93</lpage> (<year>2001</year>).<pub-id pub-id-type="pmid">11314289</pub-id></mixed-citation></ref><ref id="b22"><mixed-citation publication-type="journal"><name><surname>Bellamy</surname><given-names>N.</given-names></name>, <name><surname>Buchanan</surname><given-names>W. W.</given-names></name>, <name><surname>Goldsmith</surname><given-names>C. H.</given-names></name>, <name><surname>Campbell</surname><given-names>J.</given-names></name> &#x00026; <name><surname>Stitt</surname><given-names>L. W.</given-names></name>
<article-title>Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee</article-title>. <source>J Rheumatol.</source>
<volume>15</volume>, <fpage>1833</fpage>&#x02013;<lpage>1840</lpage> (<year>1988</year>).<pub-id pub-id-type="pmid">3068365</pub-id></mixed-citation></ref><ref id="b23"><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>J. M.</given-names></name> &#x00026; <name><surname>An</surname><given-names>J.</given-names></name>
<article-title>Cytokines, inflammation, and pain</article-title>. <source>Int Anesthesiol Clin.</source>
<volume>45</volume>, <fpage>27</fpage>&#x02013;<lpage>37</lpage> (<year>2007</year>).<pub-id pub-id-type="pmid">17426506</pub-id></mixed-citation></ref><ref id="b24"><mixed-citation publication-type="journal"><name><surname>Srinivasa</surname><given-names>S.</given-names></name>, <name><surname>Kahokehr</surname><given-names>A. A.</given-names></name>, <name><surname>Yu</surname><given-names>T. C.</given-names></name> &#x00026; <name><surname>Hill</surname><given-names>A. G.</given-names></name>
<article-title>Preoperative glucocorticoid use in major abdominal surgery: systematic review and meta-analysis of randomized trials</article-title>. <source>Ann Surg.</source>
<volume>254</volume>, <fpage>183</fpage>&#x02013;<lpage>191</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21694581</pub-id></mixed-citation></ref><ref id="b25"><mixed-citation publication-type="journal"><name><surname>Adachi</surname><given-names>Y. U.</given-names></name>
<etal/>. <article-title>Preemptive analgesia by preoperative administration of nonsteroidal anti-inflammatory drugs</article-title>. <source>Journal of Anesthesia.</source>
<volume>21</volume>(2), <fpage>294</fpage>&#x02013;<lpage>294</lpage> (<year>2007</year>).<pub-id pub-id-type="pmid">17458669</pub-id></mixed-citation></ref><ref id="b26"><mixed-citation publication-type="journal"><name><surname>Campiglia</surname><given-names>L.</given-names></name>
<etal/>. <article-title>Premedication with sublingual morphine sulphate in abdominal surgery</article-title>. <source>Clin Drug Investig.</source>
<volume>29</volume>(1), <fpage>25</fpage>&#x02013;<lpage>30</lpage> (<year>2009</year>).</mixed-citation></ref><ref id="b27"><mixed-citation publication-type="journal"><name><surname>Gharaei</surname><given-names>B.</given-names></name>
<etal/>. <article-title>Opioid-sparing effect of preemptive bolus low-dose ketamine for moderat sedation in opioid abusers undergoing extracorporeal shock wave lithotripsy: A randomized clinical trial</article-title>. <source>Anesth Analg.</source>
<volume>116</volume>, <fpage>75</fpage>&#x02013;<lpage>80</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23223117</pub-id></mixed-citation></ref><ref id="b28"><mixed-citation publication-type="journal"><name><surname>Hill</surname><given-names>C. M.</given-names></name>
<etal/>. <article-title>Pregabalin in patients with post operative dental pain</article-title>. <source>Eur J of Pain.</source>
<volume>5</volume>, <fpage>119</fpage>&#x02013;<lpage>124</lpage> (<year>2001</year>).<pub-id pub-id-type="pmid">11465977</pub-id></mixed-citation></ref><ref id="b29"><mixed-citation publication-type="journal"><name><surname>Stephens</surname><given-names>J. M.</given-names></name>, <name><surname>Pashos</surname><given-names>C. L.</given-names></name>, <name><surname>Haider</surname><given-names>S.</given-names></name> &#x00026; <name><surname>Wong</surname><given-names>J. M.</given-names></name>
<article-title>Making progress in the management of postoperative pain: A review of the cyclooxygenase 2-specific inhibitors</article-title>. <source>Pharmacotherapy.</source>
<volume>24</volume>, <fpage>1714</fpage>&#x02013;<lpage>1731</lpage> (<year>2004</year>).<pub-id pub-id-type="pmid">15585440</pub-id></mixed-citation></ref><ref id="b30"><mixed-citation publication-type="journal"><name><surname>AI-Sukhun</surname><given-names>J.</given-names></name>, <name><surname>Al-Sukhun</surname><given-names>S.</given-names></name>, <name><surname>Penttil&#x000e4;</surname><given-names>H.</given-names></name>, <name><surname>Ashammakhi</surname><given-names>N.</given-names></name> &#x00026; <name><surname>AI-Sukhun</surname><given-names>R.</given-names></name>
<article-title>Preemptive analgesic effect of low doses of celecoxib is superior to low doses of traditional nonsteroidal anti-inflammatory drugs</article-title>. <source>Journal of Craniofacial Surgery.</source>
<volume>23</volume>(23), <fpage>526</fpage>&#x02013;<lpage>529</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22421863</pub-id></mixed-citation></ref><ref id="b31"><mixed-citation publication-type="journal"><name><surname>Lunn</surname><given-names>T. H.</given-names></name>
<etal/>. <article-title>Effect of high-dose preoperative methylprednisolone on pain and recovery after total knee arthroplasty: a randomized, placebo-controlled trial</article-title>. <source>Br J Anaesth</source>
<volume>106</volume>(2), <fpage>230</fpage>&#x02013;<lpage>238</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21131371</pub-id></mixed-citation></ref><ref id="b32"><mixed-citation publication-type="journal"><name><surname>De Oliveira</surname><given-names>G. S.</given-names></name>, <name><surname>Almeida</surname><given-names>M. D.</given-names></name>, <name><surname>Benzon</surname><given-names>H. T.</given-names></name> &#x00026; <name><surname>McCarthy</surname><given-names>R. J.</given-names></name>
<article-title>Perioperative single dose systemic dexamethasone for postoperative pain: a meta-analysis of randomized controlled trials</article-title>. <source>Anesthesiology.</source>
<volume>115</volume>, <fpage>575</fpage>&#x02013;<lpage>588</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21799397</pub-id></mixed-citation></ref><ref id="b33"><mixed-citation publication-type="journal"><name><surname>Hall</surname><given-names>G. M.</given-names></name>, <name><surname>Peerbhoy</surname><given-names>D.</given-names></name>, <name><surname>Shenkin</surname><given-names>A.</given-names></name>, <name><surname>Parker</surname><given-names>C. J. R.</given-names></name> &#x00026; <name><surname>Salmon</surname><given-names>P.</given-names></name>
<article-title>Relationship of the functional recovery after hip arthroplasty to the neuroendocrine and inflammatory responses</article-title>. <source>British journal of anaesthesia.</source>
<volume>87</volume>(4), <fpage>537</fpage>&#x02013;<lpage>542</lpage> (<year>2001</year>).<pub-id pub-id-type="pmid">11878721</pub-id></mixed-citation></ref><ref id="b34"><mixed-citation publication-type="journal"><name><surname>Beloeil</surname><given-names>H.</given-names></name>, <name><surname>Asehnoune</surname><given-names>K.</given-names></name>, <name><surname>Moine</surname><given-names>P.</given-names></name>, <name><surname>Benhamou</surname><given-names>D.</given-names></name> &#x00026; <name><surname>Mazoit</surname><given-names>J. X.</given-names></name>
<article-title>Bupivacaine&#x02019;s action on the carrageenaninduced inflammatory response in mice: cytokine production by leukocytes after <italic>ex-vivo</italic> stimulation</article-title>. <source>Anesth Analg.</source>
<volume>100</volume>, <fpage>1081</fpage>&#x02013;<lpage>1086</lpage> (<year>2005</year>).<pub-id pub-id-type="pmid">15781526</pub-id></mixed-citation></ref><ref id="b35"><mixed-citation publication-type="journal"><name><surname>Sinclair</surname><given-names>R.</given-names></name>, <name><surname>Eriksson</surname><given-names>A. S.</given-names></name>, <name><surname>Gretzer</surname><given-names>C.</given-names></name>, <name><surname>Cassuto</surname><given-names>J.</given-names></name> &#x00026; <name><surname>Thomsen</surname><given-names>P.</given-names></name>
<article-title>Inhibitory effects of amide local anaesthetics on stimulus-induced human leukocyte metabolic activation, LTB4 release and IL-1 secretion <italic>in vitro</italic></article-title>. <source>Acta Anaesthesiol Scand.</source>
<volume>37</volume>, <fpage>159</fpage>&#x02013;<lpage>165</lpage> (<year>1993</year>).<pub-id pub-id-type="pmid">8383401</pub-id></mixed-citation></ref><ref id="b36"><mixed-citation publication-type="journal"><name><surname>Kerr</surname><given-names>D. R.</given-names></name> &#x00026; <name><surname>Kohan</surname><given-names>L.</given-names></name>
<article-title>Local infiltration analgesia: a technique for the control of acute postoperative pain following knee and hip surgery: a case study of 325 patients</article-title>. <source>Acta Orthop.</source>
<volume>79</volume>, <fpage>174</fpage>&#x02013;<lpage>183</lpage> (<year>2008</year>).<pub-id pub-id-type="pmid">18484242</pub-id></mixed-citation></ref><ref id="b37"><mixed-citation publication-type="journal"><name><surname>Bonnet</surname><given-names>F.</given-names></name> &#x00026; <name><surname>Marret</surname><given-names>E.</given-names></name>
<article-title>Influence of anaesthetic and analgesic techniques on outcome after surgery</article-title>. <source>British journal of anaesthesia.</source>
<volume>95</volume>, <fpage>52</fpage>&#x02013;<lpage>58</lpage> (<year>2005</year>).<pub-id pub-id-type="pmid">15579487</pub-id></mixed-citation></ref></ref-list><fn-group><fn><p><bold>Author Contributions</bold> J.X. wrote the main manuscript. J.Z. and Y.Q. designed the study and managed overall process. Y.G. undertook data management and statistical analysis. H.Z. and L.P. contributed to data management and literatures review. All authors have approved the final manuscript.</p></fn></fn-group></back><floats-group><fig id="f1"><label>Figure 1</label><caption><p>(<bold>A</bold>) Hs-CRP level after arthroplasty. Tests with repeated measurement regression. (<bold>B,C</bold>) Pain at rest and walking after arthroplasty. Tests with repeated measurement regression. (<bold>D</bold>) Range of motion (ROM) after arthroplasty. Tests with repeated measurement regression. (<sup>+</sup>P&#x02009;&#x0003c;&#x02009;0.01; <sup>++</sup>P,0.05. Blue: MMA without preemptive analgesia group; Green: MMA with preemptive analgesia group).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="srep30354-f1"/></fig><table-wrap position="float" id="t1"><label>Table 1</label><caption><title>Baseline patient characteristics and pre- and perioperative characteristics.</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50">Variable</th><th align="center" valign="top" charoff="50">MMA with preemptive analgesia group</th><th align="center" valign="top" charoff="50">MMA without preemptive analgesia group</th><th align="center" valign="top" charoff="50"><italic>P</italic>-value</th></tr></thead><tbody valign="top"><tr><td colspan="4" align="left" valign="top" charoff="50">Patient characteristics</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Age (yr)</td><td align="center" valign="top" charoff="50">67.8&#x02009;&#x000b1;&#x02009;7.2</td><td align="center" valign="top" charoff="50">68.8&#x02009;&#x000b1;&#x02009;6.5</td><td align="center" valign="top" charoff="50">0.106</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Gender (male/female)</td><td align="center" valign="top" charoff="50">12/26</td><td align="center" valign="top" charoff="50">13/24</td><td align="center" valign="top" charoff="50">0.467</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;BMI (kg m-2)</td><td align="center" valign="top" charoff="50">27.2&#x02009;&#x000b1;&#x02009;2.7</td><td align="center" valign="top" charoff="50">26.8&#x02009;&#x000b1;&#x02009;3. 1</td><td align="center" valign="top" charoff="50">0.08</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;ASA (I/II/III)</td><td align="center" valign="top" charoff="50">2/26/10</td><td align="center" valign="top" charoff="50">2/29/6</td><td align="center" valign="top" charoff="50">0.370</td></tr><tr><td colspan="4" align="left" valign="top" charoff="50">Co-morbidities</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;None</td><td align="center" valign="top" charoff="50">11</td><td align="center" valign="top" charoff="50">9</td><td align="center" valign="top" charoff="50">0.886</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Hypertension</td><td align="center" valign="top" charoff="50">15</td><td align="center" valign="top" charoff="50">17</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Diabetes</td><td align="center" valign="top" charoff="50">6</td><td align="center" valign="top" charoff="50">8</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Coronary artery disease</td><td align="center" valign="top" charoff="50">3</td><td align="center" valign="top" charoff="50">2</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;others</td><td align="center" valign="top" charoff="50">2</td><td align="center" valign="top" charoff="50">1</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Side of surgery (R/L)</td><td align="center" valign="top" charoff="50">10/28</td><td align="center" valign="top" charoff="50">12/25</td><td align="center" valign="top" charoff="50">0.372</td></tr><tr><td colspan="4" align="left" valign="top" charoff="50">Preoperative data</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Pain at rest</td><td align="center" valign="top" charoff="50">6.11&#x02009;&#x000b1;&#x02009;0.91</td><td align="center" valign="top" charoff="50">6.22&#x02009;&#x000b1;&#x02009;0.95</td><td align="center" valign="top" charoff="50">0.148</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Pain at walking</td><td align="center" valign="top" charoff="50">6.65&#x02009;&#x000b1;&#x02009;0.68</td><td align="center" valign="top" charoff="50">6.89&#x02009;&#x000b1;&#x02009;0.61</td><td align="center" valign="top" charoff="50">0.101</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Hs-CRP (&#x003bc;g/ml)</td><td align="center" valign="top" charoff="50">1.99&#x02009;&#x000b1;&#x02009;0.55</td><td align="center" valign="top" charoff="50">1.94&#x02009;&#x000b1;&#x02009;0.52</td><td align="center" valign="top" charoff="50">0.644</td></tr><tr><td colspan="4" align="left" valign="top" charoff="50">Perioperative data</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Duration of surgery (min)</td><td align="center" valign="top" charoff="50">58.5&#x02009;&#x000b1;&#x02009;8.6</td><td align="center" valign="top" charoff="50">56.1&#x02009;&#x000b1;&#x02009;8.4</td><td align="center" valign="top" charoff="50">0.686</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Bleeding intraoperatively (ml)</td><td align="center" valign="top" charoff="50">423.5&#x02009;&#x000b1;&#x02009;95.8</td><td align="center" valign="top" charoff="50">414.5&#x02009;&#x000b1;&#x02009;98.4</td><td align="center" valign="top" charoff="50">0.207</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Duration of femoral tourniquet (min)</td><td align="center" valign="top" charoff="50">24.6&#x02009;&#x000b1;&#x02009;6.4</td><td align="center" valign="top" charoff="50">23.9&#x02009;&#x000b1;&#x02009;6.1</td><td align="center" valign="top" charoff="50">0.312</td></tr></tbody></table></table-wrap><table-wrap position="float" id="t2"><label>Table 2</label><caption><title>Cumulative consumption of morphine after total knee arthroplasty.</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50">Time</th><th align="center" valign="top" charoff="50">MMA with preemptive analgesia group</th><th align="center" valign="top" charoff="50">MMA without preemptive analgesia group</th><th align="center" valign="top" charoff="50"><italic>P</italic>-value between groups</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" charoff="50">0&#x02013;24&#x02009;h</td><td align="center" valign="top" charoff="50">13.25&#x02009;&#x000b1;&#x02009;7.67</td><td align="center" valign="top" charoff="50">18.05&#x02009;&#x000b1;&#x02009;8.57</td><td align="center" valign="top" charoff="50">0.017</td></tr><tr><td align="left" valign="top" charoff="50">24&#x02013;48</td><td align="center" valign="top" charoff="50">19.08&#x02009;&#x000b1;&#x02009;7.24</td><td align="center" valign="top" charoff="50">23.05&#x02009;&#x000b1;&#x02009;9.24</td><td align="center" valign="top" charoff="50">0.023</td></tr><tr><td align="left" valign="top" charoff="50">total</td><td align="center" valign="top" charoff="50">43.28&#x02009;&#x000b1;&#x02009;14.65</td><td align="center" valign="top" charoff="50">45.03&#x02009;&#x000b1;&#x02009;15.42</td><td align="center" valign="top" charoff="50">0.113</td></tr></tbody></table></table-wrap><table-wrap position="float" id="t3"><label>Table 3</label><caption><title>Postoperative functional outcome after total knee arthroplasty.</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50">Variables</th><th align="center" valign="top" charoff="50">MMA with preemptive analgesia group</th><th align="center" valign="top" charoff="50">MMA without preemptive analgesia group</th><th align="center" valign="top" charoff="50"><italic>P</italic>-value between groups</th></tr></thead><tbody valign="top"><tr><td colspan="4" align="left" valign="top" charoff="50">2&#x02009;min walk test (m) preoperative</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;3 d postoperatively</td><td align="center" valign="top" charoff="50">17.13&#x02009;&#x000b1;&#x02009;3.82</td><td align="center" valign="top" charoff="50">14.19&#x02009;&#x000b1;&#x02009;3.56</td><td align="center" valign="top" charoff="50">0.003</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;1&#x02009;w postoperatively</td><td align="center" valign="top" charoff="50">34.08&#x02009;&#x000b1;&#x02009;5.68</td><td align="center" valign="top" charoff="50">32.05&#x02009;&#x000b1;&#x02009;6.31</td><td align="center" valign="top" charoff="50">0.149</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;2&#x02009;w postoperatively</td><td align="center" valign="top" charoff="50">71.05&#x02009;&#x000b1;&#x02009;8.65</td><td align="center" valign="top" charoff="50">67.54&#x02009;&#x000b1;&#x02009;9.99</td><td align="center" valign="top" charoff="50">0.108</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;P-value within groups</td><td align="center" valign="top" charoff="50">0.000</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td colspan="4" align="left" valign="top" charoff="50">6&#x02009;min walk test (m)</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;preoperative</td><td align="center" valign="top" charoff="50">164.53&#x02009;&#x000b1;&#x02009;27.99</td><td align="center" valign="top" charoff="50">163.32&#x02009;&#x000b1;&#x02009;31.03</td><td align="center" valign="top" charoff="50">0.392</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;1&#x02009;m postoperatively</td><td align="center" valign="top" charoff="50">205.29&#x02009;&#x000b1;&#x02009;48.11</td><td align="center" valign="top" charoff="50">195.57&#x02009;&#x000b1;&#x02009;44.39</td><td align="center" valign="top" charoff="50">0.153</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;3&#x02009;m postoperatively</td><td align="center" valign="top" charoff="50">250.29&#x02009;&#x000b1;&#x02009;46.92</td><td align="center" valign="top" charoff="50">262.16&#x02009;&#x000b1;&#x02009;47.82</td><td align="center" valign="top" charoff="50">0.735</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;6&#x02009;m postoperatively</td><td align="center" valign="top" charoff="50">247.92&#x02009;&#x000b1;&#x02009;35.70</td><td align="center" valign="top" charoff="50">266.05&#x02009;&#x000b1;&#x02009;39.58</td><td align="center" valign="top" charoff="50">0.973</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;P-value within groups</td><td align="center" valign="top" charoff="50">0.020</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td colspan="4" align="left" valign="top" charoff="50">WOMAC</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;preoperative</td><td align="center" valign="top" charoff="50">50.74&#x02009;&#x000b1;&#x02009;7.03</td><td align="center" valign="top" charoff="50">51.87&#x02009;&#x000b1;&#x02009;7.47</td><td align="center" valign="top" charoff="50">0.503</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;1&#x02009;m postoperatively</td><td align="center" valign="top" charoff="50">24.03&#x02009;&#x000b1;&#x02009;7.25</td><td align="center" valign="top" charoff="50">23.84&#x02009;&#x000b1;&#x02009;7.76</td><td align="center" valign="top" charoff="50">0.914</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;3&#x02009;m postoperatively</td><td align="center" valign="top" charoff="50">11.84&#x02009;&#x000b1;&#x02009;4.59</td><td align="center" valign="top" charoff="50">10.19&#x02009;&#x000b1;&#x02009;4.27</td><td align="center" valign="top" charoff="50">0.111</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;6&#x02009;m postoperatively</td><td align="center" valign="top" charoff="50">6.90&#x02009;&#x000b1;&#x02009;1.25</td><td align="center" valign="top" charoff="50">6.89&#x02009;&#x000b1;&#x02009;1.22</td><td align="center" valign="top" charoff="50">0.992</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;P-value within groups</td><td align="center" valign="top" charoff="50">0.000</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr></tbody></table></table-wrap><table-wrap position="float" id="t4"><label>Table 4</label><caption><title>Nausea, vomiting, and consumption of ondansetron during Perioperative period.</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50">Variable</th><th align="center" valign="top" charoff="50">MMA with preemptive analgesia group</th><th align="center" valign="top" charoff="50">MMA without preemptive analgesia group</th><th align="center" valign="top" charoff="50"><italic>P</italic>-value</th></tr></thead><tbody valign="top"><tr><td colspan="4" align="left" valign="top" charoff="50">No. of patients with nausea</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;6&#x02009;h</td><td align="center" valign="top" charoff="50">6</td><td align="center" valign="top" charoff="50">6</td><td align="center" valign="top" charoff="50">0.603</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;24&#x02009;h</td><td align="center" valign="top" charoff="50">5</td><td align="center" valign="top" charoff="50">9</td><td align="center" valign="top" charoff="50">0.203</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;2&#x02009;w</td><td align="center" valign="top" charoff="50">0</td><td align="center" valign="top" charoff="50">0</td><td align="center" valign="top" charoff="50">&#x02014;</td></tr><tr><td colspan="4" align="left" valign="top" charoff="50">No. of patients with episode (s) of vomiting</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;6&#x02009;h</td><td align="center" valign="top" charoff="50">3</td><td align="center" valign="top" charoff="50">4</td><td align="center" valign="top" charoff="50">0.515</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;24&#x02009;h</td><td align="center" valign="top" charoff="50">2</td><td align="center" valign="top" charoff="50">3</td><td align="center" valign="top" charoff="50">0.513</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;2&#x02009;w</td><td align="center" valign="top" charoff="50">0</td><td align="center" valign="top" charoff="50">0</td><td align="center" valign="top" charoff="50">&#x02014;</td></tr><tr><td colspan="4" align="left" valign="top" charoff="50">No. of patients requiring ondansetron</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;6&#x02009;h</td><td align="center" valign="top" charoff="50">1</td><td align="center" valign="top" charoff="50">2</td><td align="center" valign="top" charoff="50">0.572</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;24&#x02009;h</td><td align="center" valign="top" charoff="50">1</td><td align="center" valign="top" charoff="50">1</td><td align="center" valign="top" charoff="50">0.747</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;2&#x02009;w</td><td align="center" valign="top" charoff="50">0</td><td align="center" valign="top" charoff="50">0</td><td align="center" valign="top" charoff="50">&#x02014;</td></tr></tbody></table></table-wrap></floats-group></article>